Amit Jadhav

Director Global Patient Safety, Internal Medicine and Gene Therapy - Regeneron

Amit Jadhav is a physician with extensive experience in the pharmaceutical industry, spanning over a decade. His career includes work in Pharmacovigilance, Early and Late Phase Clinical Development within Global Patient Safety roles, and in Medical Affairs. Currently, Amit is actively involved in exploratory clinical studies, including First in Human (FIH) projects, within the fields of Gene Therapy and Rare Diseases. Amit holds the esteemed 'Diploma in Pharmaceutical Medicine' (DPM) degree from the Royal College of Physicians, UK and is a 'Member of Faculty of Pharmaceutical Medicine' (MFPM). Amit's professional experience includes strategic safety input within clinical development programs, Marketing Authorisation Application (MAA) submissions, and an important role in formulating and implementing risk minimisation measures through collaborations with global affiliates. He has also been involved in signal surveillance activities, due diligence processes, quality improvement projects, and partnerships with academic institutes for Post-Authorization Safety Studies (PASS). Additionally, Amit has engaged with Key Opinion Leaders (KOLs), participated in product launches, and collaborated with alliance and co-development partners.

Amit Jadhav


  • Wednesday - November 1, 2023 - 14:00

    Case Study: Development and implementation of additional risk minimisation measure



Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now